Literature DB >> 10870996

In vivo absorption properties of orally administered recombinant human interleukin-11.

C M Tseng1, L Albert, R L Peterson, P Bouchard, A J Dorner, J Keith, S P Khor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10870996     DOI： 10.1023/a:1007545524408

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  12 in total

1.  Pharmacokinetics of [125I]-recombinant human interleukin-11: 1. Absorption, distribution and excretion after subcutaneous administration to male rats.

Authors:  T Uchida; K Aoyama; K Mori; T Usui; T Watanabe; Y Takariki; N Asahara; M Hirose; T Kimura; M Tateishi; S Higuchi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Jul-Sep       Impact factor: 2.441

2.  Pharmacokinetics of recombinant human interleukin-11 (rhIL-11) in healthy male subjects.

Authors:  K Aoyama; T Uchida; F Takanuki; T Usui; T Watanabe; S Higuchi; T Toyoki; H Mizoguchi
Journal:  Br J Clin Pharmacol       Date:  1997-06       Impact factor: 4.335

3.  Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production.

Authors:  W L Trepicchio; M Bozza; G Pedneault; A J Dorner
Journal:  J Immunol       Date:  1996-10-15       Impact factor: 5.422

4.  Disposition characteristics of recombinant human interleukin-11 after a bolus intravenous administration in mice.

Authors:  A Takagi; H Masuda; Y Takakura; M Hashida
Journal:  J Pharmacol Exp Ther       Date:  1995-11       Impact factor: 4.030

Review 5.  The biology of interleukin 11.

Authors:  S Neben; K Turner
Journal:  Stem Cells       Date:  1993-07       Impact factor: 6.277

6.  Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease.

Authors:  R L Peterson; L Wang; L Albert; J C Keith; A J Dorner
Journal:  Lab Invest       Date:  1998-12       Impact factor: 5.662

7.  The preparation and labeling of DTPA-coupled albumin.

Authors:  D J Hnatowich; W W Layne; R L Childs
Journal:  Int J Appl Radiat Isot       Date:  1982-05

Review 8.  Preclinical biology of interleukin 11: a multifunctional hematopoietic cytokine with potent thrombopoietic activity.

Authors:  S J Goldman
Journal:  Stem Cells       Date:  1995-09       Impact factor: 6.277

9.  Alanine-scanning mutagenesis of human interleukin-11: identification of regions important for biological activity.

Authors:  M Czupryn; F Bennett; J Dube; K Grant; H Scoble; H Sookdeo; J M McCoy
Journal:  Ann N Y Acad Sci       Date:  1995-07-21       Impact factor: 5.691

10.  A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy.

Authors:  M S Gordon; W J McCaskill-Stevens; L A Battiato; J Loewy; D Loesch; E Breeden; R Hoffman; K J Beach; B Kuca; J Kaye; G W Sledge
Journal:  Blood       Date:  1996-05-01       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.